CATALOGO DEI PRODOTTI DELLA RICERCA

PIGHI, LAURA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.607
EU - Europa 2.519
AS - Asia 2.097
SA - Sud America 289
Continente sconosciuto - Info sul continente non disponibili 164
AF - Africa 129
OC - Oceania 7
Totale 8.812
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.440
RU - Federazione Russa 1.164
SG - Singapore 928
IT - Italia 562
CN - Cina 335
BR - Brasile 230
HK - Hong Kong 215
VN - Vietnam 208
BD - Bangladesh 147
FR - Francia 127
GB - Regno Unito 126
DE - Germania 125
IE - Irlanda 98
CA - Canada 81
KR - Corea 75
SE - Svezia 69
FI - Finlandia 54
ES - Italia 46
IN - India 33
PL - Polonia 32
JP - Giappone 31
NL - Olanda 31
TG - Togo 31
BJ - Benin 29
NG - Nigeria 22
AT - Austria 21
AR - Argentina 18
TN - Tunisia 18
ID - Indonesia 17
MX - Messico 17
PH - Filippine 14
CR - Costa Rica 13
TR - Turchia 13
IQ - Iraq 11
SV - El Salvador 11
CO - Colombia 10
EC - Ecuador 9
LT - Lituania 9
PT - Portogallo 9
UA - Ucraina 9
VE - Venezuela 9
BE - Belgio 8
GT - Guatemala 8
TW - Taiwan 8
ZA - Sudafrica 8
AU - Australia 7
CW - ???statistics.table.value.countryCode.CW??? 7
PK - Pakistan 7
GP - Guadalupe 6
HN - Honduras 6
PR - Porto Rico 6
SA - Arabia Saudita 6
AE - Emirati Arabi Uniti 5
BH - Bahrain 5
DK - Danimarca 5
IR - Iran 5
NI - Nicaragua 5
PE - Perù 5
DZ - Algeria 4
MA - Marocco 4
PY - Paraguay 4
TH - Thailandia 4
TT - Trinidad e Tobago 4
UZ - Uzbekistan 4
BA - Bosnia-Erzegovina 3
CL - Cile 3
KZ - Kazakistan 3
NP - Nepal 3
SK - Slovacchia (Repubblica Slovacca) 3
AZ - Azerbaigian 2
BB - Barbados 2
BG - Bulgaria 2
BY - Bielorussia 2
CH - Svizzera 2
DO - Repubblica Dominicana 2
EE - Estonia 2
ET - Etiopia 2
IL - Israele 2
JM - Giamaica 2
JO - Giordania 2
KE - Kenya 2
KG - Kirghizistan 2
LK - Sri Lanka 2
NO - Norvegia 2
OM - Oman 2
PS - Palestinian Territory 2
RS - Serbia 2
AL - Albania 1
AO - Angola 1
BF - Burkina Faso 1
BM - Bermuda 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BS - Bahamas 1
BZ - Belize 1
CI - Costa d'Avorio 1
CZ - Repubblica Ceca 1
EG - Egitto 1
EU - Europa 1
GE - Georgia 1
Totale 8.642
Salva come PNG Salva come JPEG
Città #
Singapore 531
San Jose 528
Ashburn 512
Dallas 508
Moscow 376
Chandler 244
Hong Kong 208
Council Bluffs 163
Verona 121
Milan 101
The Dalles 97
Dublin 93
Ho Chi Minh City 77
Beijing 68
Los Angeles 66
Munich 53
Hanoi 50
Buffalo 49
Santa Clara 49
New York 46
London 41
Columbus 33
Lomé 31
Rome 31
Seattle 31
Cotonou 29
Tokyo 28
Madrid 27
Redondo Beach 26
Helsinki 25
São Paulo 23
Warsaw 23
Lawrence 22
Princeton 22
Toronto 22
Montreal 21
Phoenix 21
Redmond 21
Abuja 20
Amsterdam 20
Seoul 20
Atlanta 18
Boston 18
Chicago 18
Orem 18
Sindelfingen 18
Turku 18
Frankfurt am Main 17
Wilmington 17
Houston 16
Paris 16
Denver 15
McKinney 15
North Hollywood 15
Brooklyn 14
Philadelphia 14
Vienna 14
Jakarta 13
Montecchio Maggiore 12
Poplar 12
Figino 11
Haiphong 11
San Salvador 11
Lappeenranta 10
Naples 10
Tianjin 10
Chennai 9
Guangzhou 9
Nuremberg 9
Turin 9
Annandale 8
Bari 8
Brussels 8
Da Nang 8
Hải Dương 8
Lisbon 8
San José 8
Tunis 8
Ancona 7
Ann Arbor 7
Biên Hòa 7
Charlotte 7
Shenzhen 7
Stockholm 7
Taipei 7
Willemstad 7
Brasília 6
Catania 6
Cleveland 6
Curitiba 6
Des Moines 6
Guatemala City 6
Miami 6
North Bergen 6
Pescantina 6
Reggio Emilia 6
San Francisco 6
Washington 6
Bologna 5
Bonndorf 5
Totale 5.076
Salva come PNG Salva come JPEG
Nome #
A Comparative Evaluation of the Chemiluminescence Immunoassay and ELISA for the Detection of Islet Autoantibodies in Type 1 Diabetes 272
Clinical assessment of FREND COVID-19 Ag test in an unselected population referred for routine SARS-CoV-2 testing 205
Anti-spike S1 IgA, anti-spike trimeric IgG, and anti-spike RBD IgG response after BNT162b2 COVID-19 mRNA vaccination in healthcare workers 189
Reliability of a single-nostril nasopharyngeal swab for diagnosing SARS-CoV-2 infection 181
Anti-SARS-CoV-2 Receptor-Binding Domain Total Antibodies Response in Seropositive and Seronegative Healthcare Workers Undergoing COVID-19 mRNA BNT162b2 Vaccination 180
Comparison of five commercial anti-SARS-CoV-2 total antibodies and IgG immunoassays after vaccination with BNT162b2 mRNA 180
Analytical evaluation of the novel Mindray high sensitivity cardiac troponin I immunoassay on CL-1200i 179
Effect of BNT162b2 booster dose on anti-SARS-CoV-2 spike trimeric IgG antibodies in seronegative individuals 168
Comprehensive assessment of humoral response after Pfizer BNT162b2 mRNA Covid-19 vaccination: a three-case series 166
Clinical Assessment of the DiaSorin LIAISON SARS-CoV-2 Ag Chemiluminescence Immunoassay 166
Three-month analysis of total humoral response to Pfizer BNT162b2 mRNA COVID-19 vaccination in healthcare workers 163
Preanalytical Impact of Incomplete K2EDTA Blood Tube Filling in Molecular Biology Testing 161
Differential diagnosis of lymphocytosis in routine laboratory practice: the contribution of Sysmex- XN9100 158
The pronounced decline of anti-SARS-CoV-2 spike trimeric IgG and RBD IgG in baseline seronegative individuals six months after BNT162b2 vaccination is consistent with the need for vaccine boosters 157
Assessment of humoral and cellular immunity after bivalent BNT162b2 vaccination and potential association with reactogenicity 156
Real-world assessment of Fluorecare SARS-CoV-2 Spike Protein Test Kit 156
Monitoring of the immunogenic response to Pfizer BNT162b2 mRNA COVID-19 vaccination in healthcare workers with Snibe SARS-CoV-2 S-RBD IgG chemiluminescent immunoassay 152
Methadone metabolite (EDDP) crystals in urine: a case report 144
Clinical performance of the Roche Elecsys SARS-CoV-2 antigen fully automated electrochemiluminescence immunoassay 144
Performance of Fujirebio Espline SARS-CoV-2 rapid antigen test for identifying potentially infectious individuals 142
Clinical assessment of SNIBE Maglumi SARS-CoV-2 antigen fully-automated chemiluminescent immunoassay 140
Comparative longitudinal variation of total IgG and IgA anti-SARS-CoV-2 antibodies in recipients of BNT162b2 vaccination 138
Association between viral load and positivization time of a SARS-CoV-2 rapid antigen test in routine nasopharyngeal specimens 136
SARS-CoV-2 Omicron infection is associated with high nasopharyngeal viral load 135
Improved potassium reliability in whole blood through hemolysis detection on the novel GEM Premier 7000 blood gas analyzer 134
Limitations of hemolysis-based correction for potassium measurement in hemolyzed whole blood samples 133
Evaluation of indoor hospital acclimatization of body temperature before COVID-19 fever screening 130
Are anti-SARS-CoV-2 S/N IgG/IgM antibodies always predictive of previous SARS-CoV-2 infection? 129
Accuracy of screening for hemolysis in plasma samples using a commercial urine dipstick 129
Variation of Forehead Temperature during Routine Working Shift in Hospital Laboratory Personnel: Implications for SARS-CoV-2 Screening 128
Analytical validation of hemolysis detection on GEM Premier 7000 125
Clinical assessment of Ortho VITROS SARS-CoV-2 antigen chemiluminescence immunoassay 124
Effect of syringe underfilling on the quality of venous blood gas analysis 123
Clinical performance of Fujirebio Lumipulse G SARSCoV- 2 Ag chemiluminescent immunoassay 123
Longitudinal monitoring of anti-SARS-CoV-2 RBD IgG antibodies after BNT162b2 vaccination in healthcare workers 122
Correlation Between Time to Positive Result of SARS-CoV-2 Rapid Antigen Self-Test and Viral Antigen Concentration 121
Assessing Intra- and Inter-Analyzer Imprecision in Automated Hematological Laboratories 121
Monoclonal gammopathy in SARS-CoV-2 infection 121
Evaluation of the acceptability of proposed hemolysis limits for Werfen ACL-TOP 750 CTS 120
Humoral response post-BNT162b2 single booster in pre-vaccination baseline SARS-CoV-2 seronegative and seropositive subjects 120
Impact of the COVID-19 pandemic on the volume of laboratory testing 117
Cellular immunity against SARS-CoV-2 depends on the serological status 116
Evaluating the accuracy of ChatGPT in classifying normal and abnormal blood cell morphology 114
Impact of an air bubble within the syringe on test results obtained with a modern blood gas analyzer 111
Positivization time of a COVID-19 rapid antigen self-test predicts SARS-CoV-2 viral load: a proof of concept 111
Three-month ad interim analysis of total anti-SARS-CoV-2 antibodies in healthy recipient of a single BNT162b2 vaccine booster 110
Cost-effectiveness analysis of different COVID-19 screening strategies based on rapid or laboratory-based SARS-CoV-2 antigen testing 109
Early kinetics of cellular immunity in recipients of bivalent BNT162b2 vaccine: a proof-of-concept study 108
Can cellular and humoral immunity predict response to BNT162b2 bivalent booster? 107
Serum C reactive protein predicts humoral response after BNT162b2 booster administration 106
Generative artificial intelligence (AI) for reporting the performance of laboratory biomarkers: not ready for prime time 102
Correlation between basal humoral immunogenicity and side effects after receiving the bivalent formulation of a mRNA-based vaccine 99
Real-world assessment of the clinical performance of COVID-VIRO ALL IN rapid SARS-CoV-2 antigen test 92
Analytical performance of the Roche Elecsys TnT hs Gen 6 immunoassay 91
Effect of exogenous lipids contamination on blood gas analysis 88
Serum levels of prostate specific antigen (PSA) after primary vaccination with BNT162b2 85
Monitoring humoral and cellular immunity over 6 months after mRNA-based bivalent COVID-19 vaccine administration 82
Performance assessment of ChatGPT in classification of urine particles 81
Is mixing of blood gas syringes after collection really necessary? 80
Evaluation of freely available artificial intelligence (AI) tools for diagnostic support in a complex clinical and laboratory presentations: a pilot study 80
The incremental impact of comorbidities in COVID-19-related deaths compared to patients dying from cancer or cardiovascular disease 77
Variation of Total Anti-SARS-CoV-2 Antibodies After Primary BNT162b2 Vaccination and Homologous Booster 76
Impact of BNT162b2 primary vaccination and homologous booster on anti-SARS-CoV-2 IgA antibodies in baseline seronegative healthcare workers 76
Vaccination time does not influence total anti-SARS-CoV-2 antibodies response 75
Total anti-SARS-CoV-2 antibodies measured 6 months after Pfizer-BioNTech COVID-19 vaccination in healthcare workers 73
Urine dipstick for screening plasma glucose and bilirubin in low resource settings: a proof-of-concept study 70
Humoral response is enhanced after ipsilateral double intramuscular injection of BNT162b2 COVID-19 vaccine 67
Update on Patient Self-Testing with Portable and Wearable Devices: Advantages and Limitations 65
Uso de una tira reactiva paraorina en la evaluación de las concentraciones de glucosa y bilirrubina en plasma en entornos con recursos limitados: un estudio de prueba de concepto 61
Evaluation of circadian rhythm of SARS-CoV-2 interferon-gamma release assay (IGRA) in healthy vaccinated individuals: a case-series 58
Intra-and inter-analyzer imprecision of cell population data on Sysmex XN-10 38
Predicting Iron Deficiencies Using Routine Complete Blood Cell Count Parameters: A Machine Learning Approach and Evaluation 29
Decreased Plasma Concentration of Hydrogen Sulfide in Hospitalized COVID-19 Patients: A Novel Determinant of Mortality? 21
Evaluating the influence of different anticoagulant blood collection tubes on the efficiency of circulating RNA extraction and Real-Time PCR quantification 18
Niveles séricos de antígeno prostático específico (PSA) tras vacunación primaria con BNT162b2 13
Impacto de la vacunación primaria con BNT162b2 y una dosis de refuerzo homóloga en los anticuerpos IgA contra SARS-CoV-2 en profesionales sanitarios seronegativos 13
Variación longitudinal comparativa de los anticuerpos totales, IgG e IgA contra el SARS-CoV-2 en receptores de la vacuna BNT162b2 11
Son los anticuerpos IgG e IgM contra los antígenos S y N del SARS-CoV-2 siempre predictores de infección previa por SARS-CoV-2? 11
Totale 8.812
Salva come PNG Salva come JPEG
Categoria #
all - tutte 33.431
article - articoli 32.755
book - libri 0
conference - conferenze 270
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 406
Totale 66.862
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022132 0 0 0 8 10 4 4 6 14 8 26 52
2022/2023621 36 51 58 116 31 126 23 54 63 9 29 25
2023/2024433 19 30 29 45 66 48 43 71 4 25 38 15
2024/20251.527 65 84 90 185 61 62 64 87 181 139 225 284
2025/20264.902 333 281 405 672 1.139 285 455 285 359 234 225 229
2026/20271.100 102 251 176 571 0 0 0 0 0 0 0 0
Totale 8.812